D Müller-Wieland Selected Research

D Müller-Wieland Research Topics

Disease

7	Insulin Resistance 05/2009 - 02/2000
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2000
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 11/2004
3	Diabetes Mellitus 10/2017 - 11/2004
3	Obesity 01/2005 - 09/2000
2	Heart Failure 01/2022 - 04/2017
2	Hypercholesterolemia 06/2016 - 11/2004
2	Atherosclerosis 05/2014 - 05/2001
2	Coronary Disease (Coronary Heart Disease) 05/2014 - 07/2000
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2005 - 05/2001
2	Hypertension (High Blood Pressure) 11/2004 - 05/2001
1	Chronic Renal Insufficiency 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Rare Diseases (Rare Disease) 01/2019
1	Galactosemias (Galactosemia) 01/2019
1	Gout 11/2018
1	Prediabetic State (Prediabetes) 01/2018
1	Neoplasms (Cancer) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Dyslipidemias (Dyslipidemia) 05/2014
1	Diabetic Angiopathies (Diabetic Angiopathy) 05/2014
1	Fatty Liver 05/2012
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2009
1	Hyperglycemia 07/2008
1	Hyperinsulinism (Hyperinsulinemia) 07/2008
1	Donohue Syndrome 07/2008
1	gottron type Acrogeria 02/2005
1	Premature Aging 02/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2004
1	Myocardial Infarction 11/2004
1	Glucose Intolerance 11/2004
1	Type 2 Maturity-Onset Diabetes of the Young 06/2004
1	Type 3 Maturity-Onset Diabetes of the Young 06/2004
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 05/2002
1	Abdominal Obesity 05/2001
1	Body Weight (Weight, Body) 09/2000
1	Hypertriglyceridemia 09/2000
1	Seizures (Absence Seizure) 08/2000
1	Werner Syndrome (Werner's Syndrome) 02/2000

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 10/2017 - 02/2000
6	LipidsIBA 01/2018 - 05/2001
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2000
4	LDL CholesterolIBA 01/2018 - 05/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 07/2000
3	Transcription Factors (Transcription Factor)IBA 05/2012 - 02/2000
2	alirocumabIBA 01/2018 - 10/2017
2	oxidized low density lipoproteinIBA 01/2017 - 06/2016
2	Insulin ReceptorIBA 07/2008 - 09/2000
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	EnzymesIBA 01/2019
1	galactose-1-phosphateIBA 01/2019
1	Febuxostat FDA Link 11/2018
1	Allopurinol (Remid)FDA LinkGeneric 11/2018
1	Proprotein Convertase 9IBA 01/2018
1	empagliflozinIBA 04/2017
1	PCSK9 InhibitorsIBA 01/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2014
1	CholesterolIBA 05/2014
1	Fibric Acids (Fibrates)IBA 05/2014
1	Sterol Regulatory Element Binding Protein 1IBA 05/2012
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 05/2009
1	Aryldialkylphosphatase (Paraoxonase)IBA 05/2009
1	Tyrosine (L-Tyrosine)FDA Link 03/2005
1	Proteins (Proteins, Gene)FDA Link 03/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2005
1	ets-Domain Protein Elk-1IBA 02/2005
1	GlucokinaseIBA 06/2004
1	Hepatocyte Nuclear FactorsIBA 06/2004
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 06/2004
1	Arginine Vasopressin (Argipressin)IBA 05/2002
1	Neurophysins (Neurophysin I)IBA 05/2002
1	LeptinIBA 09/2000
1	MagnesiumIBA 08/2000
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2000
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2000

Therapy/Procedure

6	Therapeutics 01/2022 - 05/2001
1	Blood Component Removal (Apheresis) 06/2016